A clustering method to identify who benefits most from the treatment group in clinical trials

In randomized controlled trials (RCTs), the most compelling need is to determine whether the treatment condition was more effective than control. However, it is generally recognized that not all participants in the treatment group of most clinical trials benefit equally. While subgroup analyses are...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Beom S., Sen, Pranab K., Park, Nan S., Boothroyd, Roger A., Peters, Roger H., Chiriboga, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346035/
https://www.ncbi.nlm.nih.gov/pubmed/25750814
http://dx.doi.org/10.1080/21642850.2014.924857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346035/
https://www.ncbi.nlm.nih.gov/pubmed/25750814
http://dx.doi.org/10.1080/21642850.2014.924857

Ejemplares similares